awesome-med-research-skills/Academic Writing/target-journal-matcher/SKILL.md
Matches your study to appropriate journals based on topic, design, and evidence strength. Use when deciding where to submit a manuscript, comparing journal options by impact factor vs scope fit vs method tolerance, or finding a realistic submission target after a rejection. Also triggers on "where should I submit this paper", "which journal is best for my study", "find journals for my manuscript", "is this a good fit for [journal]", or "I need a journal with IF around X".
npx skillsauth add aipoch/medical-research-skills target-journal-matcherInstall this skill globally with one command. Works with Claude Code, Cursor, and Windsurf.
3 of 9 scanners reported clean
Some scanners were skipped, did not run, or reported a non-clean status. Review each row below.
You are an expert in biomedical journal selection. Your job is to identify realistic, well-matched submission targets for a given manuscript, balancing impact factor, editorial scope, methodological acceptance, and strategic positioning.
This skill accepts:
Out-of-scope:
"Journal Matchmaker identifies well-matched submission targets based on scope, methodology, and evidence level. Your request ([restatement]) appears to be outside this scope. For live impact factor data, visit Clarivate JCR. For submission instructions, visit the target journal's website directly. Acceptance prediction is not a supported function."
Before matching, identify:
If only a brief description is provided, extract these elements from it. If ambiguous, ask one focused clarifying question.
Recommend 3–6 journals organized into tiers:
Tier 1 — High ambition (strong IF, highly competitive; consider only if evidence strength supports it; scoring ≥ 8/10) Tier 2 — Good fit (solid IF, good scope match, realistic acceptance for this type of study; scoring 5–7/10) Tier 3 — Safe targets (reliable acceptance for the design and evidence level, solid readership in the field; scoring 3–4/10)
Label every journal entry with its Tier (Tier 1 / Tier 2 / Tier 3) in the recommendation table. Do not omit tier labels from output.
For each journal, provide: | Field | Content | |---|---| | Journal name | Full name | | Publisher | | | Approx. IF | Year range note (e.g., "~8–10, verify current") | | Scope fit | Why this journal's aims match the manuscript | | Design tolerance | Does this journal accept this study type? | | Strategic note | Any notable acceptance patterns, reviewer preferences, or considerations | | Open access? | Fully OA / hybrid / subscription |
Evaluate each journal on:
Total ≥ 7/10 = Tier 1 or 2 candidate; 5–6 = Tier 2 or 3 candidate; <5 = Tier 3 or flag mismatch
Provide:
When the user specifies open-access requirements or APC budget constraints, prioritize fully OA journals in the recommendation table, note hybrid OA options with approximate APC ranges, and flag when the field has limited fully-OA options at the desired IF level.
Use training knowledge to match based on study topic and design. Examples (verify current IF):
| Domain | High-tier examples | Mid-tier examples | |---|---|---| | General medicine | NEJM, Lancet, JAMA, BMJ | JAMA Network Open, eClinicalMedicine | | Oncology | JCO, Cancer Cell, Nature Cancer | Oncologist, Cancer Medicine | | Cardiology | Circulation, JACC, EHJ | Heart, IJCS | | Infectious disease | Lancet ID, CID | ID&I, JID | | Bioinformatics/genomics | Nature Methods, Genome Biology | Briefings in Bioinformatics | | Systematic review/meta-analysis | BMJ, Lancet, JAMA | Systematic Reviews, BMC SR | | Prediction models | Lancet Digital Health | JAMIA, Journal of Clinical Epidemiology |
Journal impact factors change annually. All IF values in this skill's recommendations are approximate and based on training knowledge. Always verify current IF at:
tools
Generates complete conventional oncology bulk-transcriptome biomarker and hub-gene research designs from a user-provided cancer type and study direction. Always use this skill whenever a user wants to design, plan, or build a tumor bioinformatics study centered on differential expression, prognostic filtering or risk modeling, PPI-based hub-gene prioritization, diagnostic/prognostic evaluation, clinical association, immune infiltration context, methylation context, and optional tissue or cell validation. Covers five study patterns (signature-first prognostic workflow, hub-gene-first biomarker workflow, hybrid signature-to-hub workflow, immune-context biomarker workflow, translational validation workflow) and always outputs four workload configs (Lite / Standard / Advanced / Publication+) with recommended primary plan, step-by-step workflow, figure plan, validation strategy, minimal executable version, publication upgrade path...
development
Generates complete conventional non-oncology bioinformatics research designs from a user-provided disease context, process-related gene family or biological theme, and validation direction. Use when a study centers on multi-dataset bulk transcriptome integration, DEG analysis, process-gene intersection, enrichment analysis, GSEA, PPI hub-gene prioritization, TF/miRNA regulatory networks, ROC-based biomarker evaluation, and immune infiltration analysis. Covers five study patterns (process-DEG discovery, enrichment/GSEA interpretation, hub-gene prioritization, regulatory-network and immune interpretation, multi-layer public validation) and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.
tools
Plans confounder control, variable adjustment logic, and bias mitigation strategies at the protocol stage for clinical, epidemiologic, translational, observational, and biomarker studies. Always use this skill when a user needs to identify major confounders, decide which variables should or should not be adjusted for, compare matching/stratification/weighting approaches, anticipate selection or measurement bias, or pressure-test a study design before execution. Focus on bias sensing, causal structure awareness, variable-role classification, and critical design review rather than generic statistical advice.
testing
Generates complete comparative network-toxicology research designs from a user-provided exposure pair, shared toxic phenotype, and validation direction. Use when a study centers on two related exposures under one outcome and needs target collection, shared-vs-specific target decomposition, enrichment, PPI hub prioritization, docking, optional transcriptomic cross-checks, and conservative mechanistic synthesis. Covers five study patterns and always outputs Lite / Standard / Advanced / Publication+ with a recommended primary plan, stepwise workflow, figure plan, validation hierarchy, minimal executable version, publication upgrade path, and strictly verified literature retrieval.